$3.29 Billion is the total value of PFM Health Sciences, LP's 67 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 71.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BMY | Buy | BRISTOL MYERS SQUIBB CO | $196,316,000 | +59.8% | 2,853,840 | +37.5% | 5.96% | +72.5% |
WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $193,063,000 | +7.6% | 2,267,196 | +5.0% | 5.87% | +16.2% |
AGN | Sell | ALLERGAN PLC | $153,893,000 | -7.0% | 492,459 | -19.1% | 4.68% | +0.5% |
PANW | Buy | PALO ALTO NETWORKS INC | $144,233,000 | +55.3% | 818,852 | +51.7% | 4.38% | +67.8% |
AER | Buy | AERCAP HOLDINGS NV | $126,136,000 | +57.5% | 2,922,514 | +39.6% | 3.83% | +70.2% |
TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $122,153,000 | +40.6% | 1,860,952 | +20.9% | 3.71% | +51.9% |
GOOGL | New | ALPHABET INCcap stk cl a | $107,004,000 | – | 137,536 | +100.0% | 3.25% | – |
AMZN | New | AMAZON COM INC | $99,396,000 | – | 147,060 | +100.0% | 3.02% | – |
VMC | Buy | VULCAN MATLS CO | $97,181,000 | +17.2% | 1,023,285 | +10.0% | 2.95% | +26.6% |
EW | Buy | EDWARDS LIFESCIENCES CORP | $92,730,000 | -17.2% | 1,174,098 | +49.1% | 2.82% | -10.5% |
SCHW | New | SCHWAB CHARLES CORP NEW | $91,531,000 | – | 2,779,577 | +100.0% | 2.78% | – |
BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $85,482,000 | – | 1,051,826 | +100.0% | 2.60% | – |
MDCO | Buy | MEDICINES CO | $77,165,000 | +57.6% | 2,066,547 | +60.2% | 2.34% | +70.3% |
HRTX | Sell | HERON THERAPEUTICS INC | $74,158,000 | +2.6% | 2,777,464 | -6.3% | 2.25% | +10.8% |
CLVS | Sell | CLOVIS ONCOLOGY INC | $72,745,000 | -69.0% | 2,078,440 | -18.6% | 2.21% | -66.5% |
JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $71,946,000 | +66.2% | 511,850 | +57.0% | 2.19% | +79.5% |
UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $68,576,000 | +6.2% | 573,905 | +11.0% | 2.08% | +14.8% |
TXT | Buy | TEXTRON INC | $66,082,000 | +391.2% | 1,573,009 | +340.1% | 2.01% | +431.2% |
LRCX | New | LAM RESEARCH CORP | $63,920,000 | – | 804,833 | +100.0% | 1.94% | – |
ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $62,428,000 | +72.3% | 1,890,030 | +70.9% | 1.90% | +86.2% |
Sell | BRISTOL MYERS SQUIBB COcall | $60,336,000 | +14300.0% | 877,100 | -65.4% | 1.83% | +15175.0% | |
SYF | New | SYNCHRONY FINL | $59,900,000 | – | 1,969,737 | +100.0% | 1.82% | – |
AERI | Buy | AERIE PHARMACEUTICALS INC | $57,826,000 | +46.9% | 2,374,797 | +7.1% | 1.76% | +58.7% |
AET | Sell | AETNA INC NEW | $56,584,000 | -19.6% | 523,340 | -18.6% | 1.72% | -13.1% |
ACOR | Buy | ACORDA THERAPEUTICS INC | $55,077,000 | +127.4% | 1,287,443 | +40.9% | 1.67% | +145.8% |
FB | Sell | FACEBOOK INCcl a | $54,920,000 | -44.1% | 524,747 | -52.0% | 1.67% | -39.6% |
HOLX | Buy | HOLOGIC INC | $54,813,000 | -0.2% | 1,416,728 | +0.9% | 1.66% | +7.8% |
FBHS | Sell | FORTUNE BRANDS HOME & SEC IN | $49,825,000 | +3.1% | 897,740 | -11.8% | 1.51% | +11.3% |
NFLX | Buy | NETFLIX INC | $48,813,000 | +74.7% | 426,764 | +57.7% | 1.48% | +88.7% |
BLK | New | BLACKROCK INC | $43,995,000 | – | 129,200 | +100.0% | 1.34% | – |
BLUE | New | BLUEBIRD BIO INC | $42,889,000 | – | 667,840 | +100.0% | 1.30% | – |
NOW | Sell | SERVICENOW INC | $41,716,000 | -39.7% | 481,927 | -51.7% | 1.27% | -34.9% |
MIC | Sell | MACQUARIE INFRASTRUCTURE COR | $40,914,000 | -31.4% | 563,552 | -29.4% | 1.24% | -25.9% |
HD | Sell | HOME DEPOT INC | $36,604,000 | -39.8% | 276,778 | -47.4% | 1.11% | -35.0% |
MOH | Buy | MOLINA HEALTHCARE INC | $35,354,000 | +124.6% | 587,956 | +157.2% | 1.07% | +142.4% |
ARAY | Sell | ACCURAY INC | $34,588,000 | +20.0% | 5,124,148 | -11.2% | 1.05% | +29.6% |
KITE | Sell | KITE PHARMA INC | $34,287,000 | -9.8% | 556,433 | -18.5% | 1.04% | -2.5% |
URI | New | UNITED RENTALS INC | $28,774,000 | – | 396,663 | +100.0% | 0.87% | – |
MSFT | New | MICROSOFT CORP | $27,304,000 | – | 492,143 | +100.0% | 0.83% | – |
HCA | Sell | HCA HOLDINGS INC | $27,175,000 | -85.2% | 401,817 | -83.0% | 0.83% | -84.0% |
CHTR | New | CHARTER COMMUNICATIONS INC Dcl a new | $26,609,000 | – | 145,325 | +100.0% | 0.81% | – |
BPMC | Sell | BLUEPRINT MEDICINES CORP | $26,557,000 | +26.3% | 1,008,232 | -1.9% | 0.81% | +36.3% |
THRX | New | THERAVANCE INC | $24,365,000 | – | 2,311,681 | +100.0% | 0.74% | – |
HDP | Buy | HORTONWORKS INC | $24,175,000 | +87.3% | 1,103,877 | +87.3% | 0.74% | +102.5% |
GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $22,760,000 | -28.9% | 703,987 | -7.2% | 0.69% | -23.1% |
UNH | Sell | UNITEDHEALTH GROUP INC | $20,551,000 | -87.9% | 174,697 | -88.1% | 0.62% | -87.0% |
CELG | New | CELGENE CORP | $19,149,000 | – | 159,895 | +100.0% | 0.58% | – |
VYGR | New | VOYAGER THERAPEUTICS INC | $17,088,000 | – | 896,634 | +100.0% | 0.52% | – |
RAD | Sell | RITE AID CORP | $15,190,000 | -30.2% | 1,937,467 | -45.9% | 0.46% | -24.5% |
ZLTQ | Buy | ZELTIQ AESTHETICS INC | $14,661,000 | +2.7% | 513,884 | +15.3% | 0.44% | +10.7% |
DXCM | New | DEXCOM INC | $14,418,000 | – | 176,038 | +100.0% | 0.44% | – |
MCK | New | MCKESSON CORP | $14,324,000 | – | 72,627 | +100.0% | 0.44% | – |
KURA | New | KURA ONCOLOGY INC | $12,551,000 | – | 1,494,169 | +100.0% | 0.38% | – |
New | CLOVIS ONCOLOGY INCcall | $11,379,000 | – | 325,100 | +100.0% | 0.35% | – | |
MYOK | New | MYOKARDIA INC | $10,243,000 | – | 698,694 | +100.0% | 0.31% | – |
Sell | OREXIGEN THERAPEUTICS INCnote 2.750%12/0 | $10,034,000 | -17.1% | 16,788,000 | -3.8% | 0.30% | -10.3% | |
AMAG | New | AMAG PHARMACEUTICALS INC | $8,526,000 | – | 282,420 | +100.0% | 0.26% | – |
DMTX | New | DIMENSION THERAPEUTICS INC | $8,385,000 | – | 815,359 | +100.0% | 0.26% | – |
GILD | Sell | GILEAD SCIENCES INC | $6,697,000 | -93.9% | 66,187 | -94.1% | 0.20% | -93.5% |
JUNO | Buy | JUNO THERAPEUTICS INC | $6,626,000 | +121.2% | 150,684 | +104.6% | 0.20% | +139.3% |
Sell | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $3,988,000 | -50.4% | 4,637,000 | -3.5% | 0.12% | -46.5% | |
CHRS | Sell | COHERUS BIOSCIENCES INC | $3,964,000 | -33.1% | 172,638 | -41.6% | 0.12% | -28.1% |
TEAM | New | ATLASSIAN CORP PLCcl a | $2,959,000 | – | 98,357 | +100.0% | 0.09% | – |
PEN | Sell | PENUMBRA INC | $2,504,000 | -83.6% | 46,531 | -87.8% | 0.08% | -82.3% |
SAGE | New | SAGE THERAPEUTICS INC | $2,382,000 | – | 40,850 | +100.0% | 0.07% | – |
RGNX | Buy | REGENXBIO INC | $1,977,000 | -16.4% | 119,092 | +11.0% | 0.06% | -9.1% |
MXL | Buy | MAXLINEAR INCcl a | $1,200,000 | +18.5% | 81,443 | +0.1% | 0.04% | +28.6% |
Exit | MCKESSON CORPcall | $0 | – | -343,100 | -100.0% | -0.00% | – | |
Exit | ROCKWELL AUTOMATION INCcall | $0 | – | -388,600 | -100.0% | -0.00% | – | |
Exit | PFIZER INCcall | $0 | – | -2,207,400 | -100.0% | -0.01% | – | |
TDOC | Exit | TELADOC INC | $0 | – | -13,670 | -100.0% | -0.01% | – |
KERX | Exit | KERYX BIOPHARMACEUTICALS INC | $0 | – | -97,687 | -100.0% | -0.01% | – |
Exit | TEVA PHARMACEUTICAL INDS LTDcall | $0 | – | -2,713,000 | -100.0% | -0.03% | – | |
Exit | PTC THERAPEUTICS INCcall | $0 | – | -428,200 | -100.0% | -0.04% | – | |
KYTH | Exit | KYTHERA BIOPHARMACEUTICALS I | $0 | – | -20,589 | -100.0% | -0.04% | – |
Exit | MERCK & CO INC NEWput | $0 | – | -1,301,300 | -100.0% | -0.05% | – | |
Exit | ALLERGAN PLCcall | $0 | – | -314,700 | -100.0% | -0.07% | – | |
FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -506,920 | -100.0% | -0.10% | – |
DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -273,965 | -100.0% | -0.27% | – |
ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $0 | – | -1,002,953 | -100.0% | -0.34% | – |
BCR | Exit | BARD C R INC | $0 | – | -75,570 | -100.0% | -0.40% | – |
AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -996,112 | -100.0% | -0.71% | – |
THOR | Exit | THORATEC CORP | $0 | – | -432,577 | -100.0% | -0.77% | – |
LBTYK | Exit | LIBERTY GLOBAL PLC | $0 | – | -680,964 | -100.0% | -0.79% | – |
LNKD | Exit | LINKEDIN CORP | $0 | – | -151,848 | -100.0% | -0.81% | – |
HUM | Exit | HUMANA INC | $0 | – | -186,935 | -100.0% | -0.94% | – |
MTG | Exit | MGIC INVT CORP WIS | $0 | – | -4,104,737 | -100.0% | -1.07% | – |
RDUS | Exit | RADIUS HEALTH INC | $0 | – | -577,034 | -100.0% | -1.12% | – |
EXP | Exit | EAGLE MATERIALS INC | $0 | – | -586,800 | -100.0% | -1.13% | – |
GOOGL | Exit | GOOGLE INCcl a | $0 | – | -66,310 | -100.0% | -1.19% | – |
JD | Exit | JD COM INCspon adr cl a | $0 | – | -1,693,324 | -100.0% | -1.24% | – |
MA | Exit | MASTERCARD INCcl a | $0 | – | -500,093 | -100.0% | -1.27% | – |
ALLY | Exit | ALLY FINL INC | $0 | – | -2,348,383 | -100.0% | -1.35% | – |
PCLN | Exit | PRICELINE GRP INC | $0 | – | -45,878 | -100.0% | -1.60% | – |
BRCM | Exit | BROADCOM CORPcl a | $0 | – | -1,271,730 | -100.0% | -1.84% | – |
LLY | Exit | LILLY ELI & CO | $0 | – | -1,106,139 | -100.0% | -2.60% | – |
PFE | Exit | PFIZER INC | $0 | – | -5,279,394 | -100.0% | -4.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
HUMANA INC | 37 | Q3 2023 | 3.8% |
EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
PENUMBRA INC | 33 | Q3 2023 | 4.8% |
AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
Erasca, Inc. | February 14, 2023 | ? | ? |
Generation Bio Co. | February 14, 2023 | ? | ? |
IO Biotech, Inc. | February 14, 2023 | ? | ? |
Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
Outset Medical, Inc. | February 14, 2023 | ? | ? |
uniQure N.V. | February 14, 2023 | ? | ? |
AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G | 2023-04-21 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.